BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26908293)

  • 1. Cognitive impairment in schizophrenia across age groups: a case-control study.
    Mosiołek A; Gierus J; Koweszko T; Szulc A
    BMC Psychiatry; 2016 Feb; 16():37. PubMed ID: 26908293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive functions in patients with familial versus sporadic schizophrenia and their parents.
    Erol A; Bayram S; Kosger F; Mete L
    Neuropsychobiology; 2012; 66(2):93-9. PubMed ID: 22814285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia.
    Nenadic I; Langbein K; Dietzek M; Forberg A; Smesny S; Sauer H
    Psychiatry Res; 2015 Nov; 230(1):65-9. PubMed ID: 26319738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. a case-control study.
    Scala S; Lasalvia A; Cristofalo D; Bonetto C; Ruggeri M
    Psychiatry Res; 2012 Dec; 200(2-3):137-43. PubMed ID: 22652345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.
    Mahurin RK; Velligan DI; Miller AL
    Psychiatry Res; 1998 Jun; 79(2):139-49. PubMed ID: 9705052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Use and Cognitive Impairment in Patients With Type 1 Diabetes: An Observational Study.
    Moryś JM; Kozera GM; Neubauer-Geryk J; Kruszewski P; Wolnik B; Nyka WM; Bieniaszewski L
    Clin Neuropharmacol; 2016; 39(4):182-7. PubMed ID: 27046662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karolinska Scales of Personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls.
    Nilsson BM; Holm G; Ekselius L
    Nord J Psychiatry; 2016; 70(1):53-61. PubMed ID: 26086780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semantic fluency and executive functions as candidate endophenotypes for the early diagnosis of schizophrenia in Han Chinese.
    Hu M; Chen J; Li L; Zheng Y; Wang J; Guo X; Wu R; Zhao J
    Neurosci Lett; 2011 Sep; 502(3):173-7. PubMed ID: 21827833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders.
    Fagerlund B; Pagsberg AK; Hemmingsen RP
    Schizophr Res; 2006 Jul; 85(1-3):30-9. PubMed ID: 16626945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic symptoms and neurocognition: preliminary comparison of first-episode psychosis vs multi-episode long-term illness].
    Savoja V; Carzedda F; Falcone I; De Carolis A; Comparelli A; Nicolò G; Kotzalidis GD; Emili E; Comazzetto C; Angelone M; Del Casale A; Ducci G; Tatarelli R; Girardi P
    Riv Psichiatr; 2013; 48(4):328-34. PubMed ID: 24056832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive function in first-episode schizophrenia: a three-year longitudinal study of an ecologically valid test.
    Liu KC; Chan RC; Chan KK; Tang JY; Chiu CP; Lam MM; Chan SK; Wong GH; Hui CL; Chen EY
    Schizophr Res; 2011 Mar; 126(1-3):87-92. PubMed ID: 21194894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderator variables of executive functioning in schizophrenia: meta-analytic findings.
    Johnson-Selfridge M; Zalewski C
    Schizophr Bull; 2001; 27(2):305-16. PubMed ID: 11354597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.